- Report
- March 2024
- 187 Pages
Global
From €3216EUR$3,374USD£2,759GBP
€3573EUR$3,749USD£3,065GBP
- Report
- May 2024
- 377 Pages
Global
From €4718EUR$4,950USD£4,047GBP
- Report
- July 2023
- 147 Pages
Global
From €2382EUR$2,499USD£2,043GBP
- Report
- April 2023
- 120 Pages
Global
From €4527EUR$4,750USD£3,884GBP
- Report
- October 2023
- 96 Pages
Global
From €3500EUR$3,934USD£3,107GBP
- Report
- October 2023
- 93 Pages
Global
From €3500EUR$3,934USD£3,107GBP
- Report
- March 2020
Japan, United States, ... Japan, United States, Europe
From €1382EUR$1,450USD£1,186GBP
The Myoglobin Test is a point-of-care diagnostic test used to detect the presence of myoglobin, a protein found in muscle tissue. It is used to diagnose muscle damage, such as that caused by a heart attack or stroke. The test is typically performed using a finger-prick blood sample, and results are available within minutes. The Myoglobin Test market is driven by the increasing prevalence of cardiovascular diseases, as well as the need for rapid diagnosis and treatment. The test is also used to monitor the effectiveness of treatments for muscle damage.
The Myoglobin Test market is highly competitive, with a number of companies offering products. These include Abbott, Roche, Siemens, and Alere. Show Less Read more